BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16856717)

  • 1. Toxicogenomics in regulatory ecotoxicology.
    Ankley GT; Daston GP; Degitz SJ; Denslow ND; Hoke RA; Kennedy SW; Miracle AL; Perkins EJ; Snape J; Tillitt DE; Tyler CR; Versteeg D
    Environ Sci Technol; 2006 Jul; 40(13):4055-65. PubMed ID: 16856717
    [No Abstract]   [Full Text] [Related]  

  • 2. TRC: Mission accomplished.
    Hood E
    Environ Health Perspect; 2007 Feb; 115(2):A81-2. PubMed ID: 17384751
    [No Abstract]   [Full Text] [Related]  

  • 3. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecotoxicology becomes stress ecology.
    Van Straalen NM
    Environ Sci Technol; 2003 Sep; 37(17):324A-330A. PubMed ID: 12967088
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions.
    Tralau T; Oelgeschläger M; Gürtler R; Heinemeyer G; Herzler M; Höfer T; Itter H; Kuhl T; Lange N; Lorenz N; Müller-Graf C; Pabel U; Pirow R; Ritz V; Schafft H; Schneider H; Schulz T; Schumacher D; Zellmer S; Fleur-Böl G; Greiner M; Lahrssen-Wiederholt M; Lampen A; Luch A; Schönfelder G; Solecki R; Wittkowski R; Hensel A
    Arch Toxicol; 2015 Jun; 89(6):823-50. PubMed ID: 25820917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-of-the-art genomics approaches in toxicology.
    Van Hummelen P; Sasaki J
    Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of toxicogenomics.
    Hamadeh HK; Amin RP; Paules RS; Afshari CA
    Curr Issues Mol Biol; 2002 Apr; 4(2):45-56. PubMed ID: 11931569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxicogenomics in hazard assessment of chemicals].
    Kostka G; Liszewska M; Urbanek-Olejnik K
    Rocz Panstw Zakl Hig; 2010; 61(2):119-27. PubMed ID: 20839457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1.2 Aspects of test assessment.
    Hoffmann S
    Hum Exp Toxicol; 2009 Feb; 28(2-3):95-6. PubMed ID: 19713368
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges to environmental toxicology and epidemiology: where do we stand and which way do we go?
    Pesch B; Brüning T; Frentzel-Beyme R; Johnen G; Harth V; Hoffmann W; Ko Y; Ranft U; Traugott UG; Thier R; Taeger D; Bolt HM
    Toxicol Lett; 2004 Jun; 151(1):255-66. PubMed ID: 15177661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data gaps threaten chemical safety law.
    Gilbert N
    Nature; 2011 Jul; 475(7355):150-1. PubMed ID: 21753825
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of omics data in regulatory toxicology: report of an international BfR expert workshop.
    Marx-Stoelting P; Braeuning A; Buhrke T; Lampen A; Niemann L; Oelgeschlaeger M; Rieke S; Schmidt F; Heise T; Pfeil R; Solecki R
    Arch Toxicol; 2015 Nov; 89(11):2177-84. PubMed ID: 26486796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of toxicogenomics.
    Waring JF; Halbert DN
    Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forthcoming Challenges in Mycotoxins Toxicology Research for Safer Food-A Need for Multi-Omics Approach.
    Dellafiora L; Dall'Asta C
    Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28054977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From alternative methods to a new toxicology.
    Hartung T
    Eur J Pharm Biopharm; 2011 Apr; 77(3):338-49. PubMed ID: 21195172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When drugs development meets genomics.
    Leung YF; Lam DS; Pang CP
    Pharmacogenomics J; 2001; 1(4):237-8. PubMed ID: 11908765
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicogenomics: the new frontier in risk analysis.
    Simmons PT; Portier CJ
    Carcinogenesis; 2002 Jun; 23(6):903-5. PubMed ID: 12082011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
    Blaauboer BJ
    Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.